A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
CRISPR Therapeutics
7 Hills Pharma, LLC
Incyte Corporation
NuCana plc
Medicenna Therapeutics, Inc.
University Hospital, Antwerp
NGM Biopharmaceuticals, Inc
Rain Oncology Inc
Western Sydney Local Health District
Institut Bergonié
Incyte Corporation
Incyte Corporation
Shenzhen BinDeBio Ltd.